Showing 1 - 5 results of 5 for search 'Monika Pizon', query time: 0.03s Refine Results
  1. 1
    Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients.

    Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer... by Monika Pizon, Dorothea Sonja Zimon, Ulrich Pachmann, Katharina Pachmann

    Published 2013-01-01
    Get full text
    Article
  2. 2
    Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer

    Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer by Monika Pizon, Daniel Lux, Ulrich Pachmann, Katharina Pachmann, Dorothea Schott

    Published 2018-12-01
    Get full text
    Article
  3. 3
    Promising Strategies in Plant-Derived Treatments of Psoriasis-Update of In Vitro, In Vivo, and Clinical Trials Studies

    Promising Strategies in Plant-Derived Treatments of Psoriasis-Update of In Vitro, In Vivo, and Clinical Trials Studies by Martyna Nowak-Perlak, Krzysztof Szpadel, Izabella Jabłońska, Monika Pizon, Marta Woźniak

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer

    Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer by Matthias Mäurer, Dorothea Schott, Monika Pizon, Sonia Drozdz, Thomas Wendt, Andrea Wittig, Katharina Pachmann

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research

    Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research by Benedikt J. Wagner, Andreas Ettner-Sitter, Nicolas A. Ihlo, Merle Behr, Sebastian Koelbl, Stefan M. Brunner, Florian Weber, Bettina M. Rau, Hans J. Schlitt, Christoph Brochhausen, Rebecca Schoenmehl, Annalena Artinger, Dorothea Schott, Monika Pizon, Katharina Pachmann, Thiha Aung, Silke Haerteis, Christina Hackl

    Published 2025-01-01
    Get full text
    Article

Search Tools: